Olema Pharmaceuticals, Inc. (OLMA) › Operating Cash FlowOlema Pharmaceuticals, Inc. (OLMA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2019: -$3.08M2020: -$19.87M2021: -$50.69M2022: -$82.06M2023: -$83.73M2024: -$104.35M2025: -$146.72M-$146.72M2019Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$146.72M-40.6%2024-$104.35M-24.6%2023-$83.73M-2.0%2022-$82.06M-61.9%2021-$50.69M-155.2%2020-$19.87M-544.8%2019-$3.08M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share